That call saved my life.
When Eric Morrow first asked about prostate cancer screening at 45, medicine told him he was too young to worry — a verdict he accepted, even as his father's diagnosis lingered in the back of his mind. It took a chance observation during a routine colonoscopy, a persistent follow-up call from a doctor he barely knew, and a PSA level of 225 to reveal how dangerously wrong that reassurance had been. Now cancer-free at 54, Morrow stands as a quiet argument against the gap between standard guidelines and individual risk — a reminder that the questions we keep asking, even when turned away, are sometimes the ones that save our lives.
- A PSA level of 225 — more than fifty times the threshold for concern — landed on a 49-year-old man who had been told for years he was simply too young to screen.
- The diagnosis arrived in the same weeks he and his wife closed on a new house, turning a moment of hope into a reckoning with debt, mortality, and two teenage children watching their father absorb the news.
- Walter Reed's team offered not a promise of cure but a frank strategy — surgery, radiation, and hormone therapy — designed to buy time and outpace the cancer until better treatments could emerge.
- By April 2022, after 39 rounds of radiation and two years of hormone therapy, his PSA had dropped from 225 to undetectable, and it has remained there ever since.
- He now trains to summit Kilimanjaro and sits with newly diagnosed patients at Walter Reed, turning his survival into a living rebuttal of the idea that prostate cancer is an old man's disease.
Eric Morrow first raised the question of prostate cancer screening at 45, after his father was diagnosed. His doctor told him he was too young — guidelines didn't recommend it until 55 — and that answer followed him through appointment after appointment for years. He kept writing it on his medical history forms. The answer never changed.
In the fall of 2020, a routine colonoscopy changed everything. The gastroenterologist noticed an enlarged prostate and suggested a urologist visit. Morrow, working 80-hour weeks in medical device sales, let the appointment slide — until the GI doctor's office called a month later to check in. That follow-up call, he would later say, saved his life.
The urologist at Andrews Air Force Base ordered a PSA test. Four hours later, the result came back: 225. Anything over 4 warranted concern. A biopsy in June 2021 confirmed adenocarcinoma — aggressive, and already spread to the pelvic lymph nodes. Stage 3B. Morrow printed the results from the patient portal one evening and handed them to his wife, Lori. It was a long night.
The timing of what followed felt almost deliberately cruel. As the couple moved into a newly purchased home, an MRI confirmed metastasis. Morrow found himself calculating debt, wondering whether he was leaving his family a mortgage he might not live to pay off. He had two teenage children and wanted more than five-year survival statistics.
Walter Reed took him on. In a full-day appointment, he and Lori met jointly with a radiation oncologist and a urologic oncologist — Lori taking notes so Morrow could focus on listening. The doctors were direct: the cancer was very aggressive, but he was young and otherwise healthy. Their plan was equally aggressive — surgery, radiation, and hormone therapy — framed not as a cure, but as the best available strategy to buy time while new treatments emerged. Morrow appreciated the honesty.
Surgery came on July 19, 2021. Lori was first in the waiting room and last to leave. Recovery was grueling — blood pressure drops during the procedure, a catheter, medications through the night, Lori waking to help him to the bathroom. Six weeks later, his PSA had fallen from 225 to 6.1. The doctors wanted it lower. He began two years of hormone therapy and 39 sessions of radiation. By April 2022, his PSA was undetectable. It has stayed that way.
Now 54, Morrow volunteers at Walter Reed and is training to climb Kilimanjaro for Zero Prostate Cancer — a goal he says he would have laughed at four years ago when he was afraid he was going to die. His message to other men is straightforward: prostate cancer is not only an older man's disease, family history matters, and asking for screening — even when turned away — can be the difference between catching it in time and catching it too late.
Eric Morrow was 45 years old when he asked his doctor about prostate cancer screening. His father had just been diagnosed. The doctor told him he was too young—screening guidelines didn't recommend it until 55. Morrow accepted this and moved on, though he kept writing it down on his medical history forms year after year, sometimes mentioning it at appointments. His doctors kept giving him the same answer.
Then, in the fall of 2020, at age 49, Morrow went in for a colonoscopy. He was overdue for one—the guidelines for that screening had shifted to 45. During the procedure, the gastroenterologist noticed something: his prostate was enlarged. The doctor suggested he see a urologist. Morrow meant to follow up. He was working 80 hours a week in medical device sales. The appointment kept sliding down his to-do list. A month later, the GI doctor's office called to check in, to make sure he'd scheduled that urologist visit. That call, Morrow would later understand, saved his life.
The urologist at Andrews Air Force Base felt something unusual during the exam and ordered a PSA test. Four hours later, the doctor called back. Morrow's PSA was 225. At his age, anything over 4 raised concern. The biopsy came back in early June 2021 with a single word that changed everything: adenocarcinoma. He logged onto the patient portal one evening, saw the results, printed them out, and handed the report to his wife, Lori. It was a long night.
Within days, Morrow learned the cancer was aggressive and had spread beyond the prostate to the pelvic lymph nodes—Stage 3B. He and Lori had just closed on a new house. As they moved in, a call came with the MRI results confirming metastasis. The timing felt cruel. He was thinking about debt, about whether he was saddling his family with a mortgage he might not live long enough to pay off. He had two teenage children. He wanted more than five-year survival statistics.
Walter Reed National Military Medical Center took him on as a patient. At a full-day appointment there, Morrow and Lori met with both a radiation oncologist and a urologic oncologist together. Lori took notes so Morrow could focus on listening and asking questions. The doctors were direct: he was young and otherwise healthy, but the cancer was very aggressive. They proposed an aggressive response—surgery, radiation, and hormone therapy combined. They framed it not as a cure they expected, but as the best chance to buy him time, to get him three to five years before recurrence, hoping that new treatments would emerge in the meantime. Morrow liked the clarity of that plan.
Surgery came on July 19, 2021. Lori was the first person in the waiting room that morning and the last to leave at the end of the day. Covid restrictions meant she couldn't stay overnight. There were moments when his blood pressure dropped dangerously low, but he went home the next day. Recovery was brutal—he felt like he'd gone ten rounds with Mike Tyson. Lori woke in the night to help him with medications, to empty the catheter bag, to get him to the bathroom. At his six-week follow-up, his PSA had dropped from 225 to 6.1. The doctor wanted it lower still. Morrow began a two-year course of hormone therapy—a shot every three months, a pill every day—and started radiation after New Year's, 39 sessions over two months. By April 2022, his PSA was undetectable. It has stayed that way.
Now 54, Morrow volunteers at Walter Reed, telling his story to newly diagnosed patients. He's training to climb Kilimanjaro in September as part of a fundraising challenge for Zero Prostate Cancer, a climb he said he would have laughed at four years ago when he was terrified he was going to die. His goal is simple: to show men that you can come back from prostate cancer treatment and still do big things. More than that, he wants younger men with family history to know that prostate cancer is not just an older man's problem, and that asking for screening—and asking again—can make the difference between catching it too late and catching it in time to fight.
Notable Quotes
For the majority of men, prostate cancer is life-altering, but it doesn't have to be life-limiting.— Eric Morrow
My goal in climbing 19,341 feet is to show men everywhere that you can come back after prostate cancer treatment and still do big things.— Eric Morrow
The Hearth Conversation Another angle on the story
What made you finally push for that screening, after your doctor said no?
I didn't, really. I kept asking, and they kept saying no. What changed was the colonoscopy. A different doctor, a GI doctor, noticed my prostate was enlarged. And then his office called to follow up. That call—that was the thing.
So it wasn't persistence on your part. It was luck.
It was luck. But it was also that one doctor who cared enough to make sure I followed through. If he hadn't called, I probably would have let it go.
Your PSA jumped from 2.3 at 40 to 225 at 49. That's a massive change in nine years.
Yes. And I had no idea it was happening. I wasn't being monitored. If I'd been screened regularly, we might have caught it earlier, when it was still contained in the prostate.
Do you think about that—what might have been different?
Every day. But I can't live there. What I can do is tell other men: if you have family history, push for screening. Don't accept no for an answer.
Your wife was in every appointment, taking notes. How much did that matter?
Everything. I was terrified. I couldn't think straight. She asked questions I wouldn't have thought to ask. She was my anchor.
And now you're climbing a mountain.
Now I'm climbing a mountain. Four years ago, I thought I was dying. Now I'm raising money and showing other men that this doesn't have to be the end of your story.